Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Compulsory Acqn of Shares

21 Nov 2022 07:00

RNS Number : 6951G
CATCo Reinsurance Opps Fund Ltd
21 November 2022
 

CATCo Reinsurance Opportunities Fund Limited (the "Company")

21 November 2022

Partial Compulsory Redemption of Shares

This announcement contains inside information

Further to the approval given by the Company's Shareholders on 6 April 2020 to enable compulsory redemptions of the Ordinary Shares and C Shares (as described in the Circular to Shareholders dated 13 March 2020), the Company today announces that it will return an aggregate amount of approximately USD 17.8m on 29 November 2022 (the "Redemption Date") by way of a compulsory partial redemption of up to 1,379,103 Ordinary Shares and 754,104 C Shares (the "Eighth Redemption"). Approximately 91.73% of the Company's total issued share capital will be redeemed (consisting of 92.36% of the Ordinary Shares currently in issue, and 90.60% of the C Shares).

The Eighth Redemption will be effected at USD 3.3355 per Ordinary Share and USD 17.5042 per C Share, being the relevant respective NAV per Ordinary Share and NAV per C Share, as at 30 September 2022. The Redemption will be effected pro rata to holdings of Ordinary Shares and C Shares respectively on the register at the close of business on the Redemption Date, which is the record date for the purposes of the Eighth Redemption, being 29 November 2022. As at today's date, the Company has 1,493,131 Ordinary Shares and 832,376 C Shares in issue, the total number of Shares in issue being 2,325,507.

Fractions of Ordinary Shares and C Shares will not be redeemed and so the number of Ordinary Shares and C Shares to be redeemed for each shareholder will be rounded down to the nearest whole number of Ordinary Shares and C Shares, as appropriate.

The amount to be applied to the partial redemption of Ordinary Shares and C Shares comprises monies from the Company's existing cash balances.

All Ordinary Shares and C Shares that are redeemed will be cancelled with effect from the relevant Redemption Date. Accordingly, once redeemed, Ordinary Shares and C Shares will be incapable of transfer.

The Ordinary Shares and C Shares will be disabled in CREST after close of business on the Redemption Date and the existing ISIN numbers, BMG1961Q2905 for the Ordinary Shares and BMG1961Q3085 for the C Shares, (the "Old ISINs") will expire.

The new ISIN numbers, which are BMG1961Q3242 in respect of the remaining Ordinary Shares and BMG1961Q3168 in respect of the remaining C Shares which have not been redeemed (the "New ISINs") will be enabled and available for transactions from and including 30 November 2022.

Up to and including the Redemption Date, Ordinary Shares and C Shares will continue to be traded under the Old ISINs and as such, a purchaser of such Ordinary Shares or C Shares, as the case may be, would have a market claim for a proportion of the redemption proceeds. CREST will automatically transform any open transactions as at the Redemption Date into the New ISINs. The Ordinary Shares and C Shares will be marked Ex in relation to the Eighth Redemption on 30 November 2022.

Shareholders should note that the Board retains absolute discretion as to the execution, extent and timing of any further returns of capital.

Expected timetable for redemption:

Announcement of redemption notice

21 November 2022

Redemption Record Date

29 November 2022

Redemption Date and expiry of Old ISIN numbers

29 November 2022

New ISIN numbers enabled

30 November 2022

Ex Date for Ordinary and C Shares

30 November 2022

Redemption monies paid to uncertificated holdings and certificated holdings

6 December 2022

Redemption monies paid to certificated holdings

8 December 2022

 

Capitalised terms used but not defined in this announcement shall bear the meanings ascribed to them in the Circular to Shareholders dated 13 March 2020.

 

Enquiries:

For further information:

 

Markel CATCo Investment Management Ltd.

 

Judith Wynne

General Counsel

Telephone: +1 441 493 9005

Email: judith.wynne@markelcatco.com

 

Mark Way

Chief of Investor Marketing

Telephone: +1 441 493 9001

Email: mark.way@markelcatco.com

 

Numis Securities Limited

 

David Benda / Hugh Jonathan

Telephone: +44 (0) 20 7260 1000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CASXQLLFLFLFFBE
Date   Source Headline
16th May 200612:41 pmRNSEPT Disclosure
16th May 200612:17 pmRNSEPT Disclosure
16th May 200611:42 amRNSEPT Disclosure
16th May 200610:45 amRNSRule 8.3- Cambridge Antibody
15th May 20062:56 pmRNSRule 8.3- Cambridge Antibody
15th May 20067:03 amRNSOffer for Cambridge Antibody
15th May 20067:03 amRNSStatement
13th Apr 200610:03 amRNSBlocklisting Interim Review
13th Apr 200610:00 amRNSBlocklisting Interim Review
13th Apr 200610:00 amRNSBlocklisting Interim Review
13th Apr 20069:52 amRNSBlocklisting Interim Review
7th Apr 20061:12 pmRNSHolding(s) in Company
6th Mar 200611:03 amRNS20-F filing
3rd Mar 200611:07 amRNSHolding(s) in Company
9th Feb 20065:23 pmRNSDirector/PDMR Shareholding
9th Feb 200610:49 amRNSDirector/PDMR Shareholding
6th Feb 20067:01 amRNS1st Quarter Results
3rd Feb 20063:30 pmRNSAGM Statement
3rd Feb 20061:00 pmRNSRe: Q1 2006 Statement
31st Jan 20069:22 amRNSNotice of Results
25th Jan 20063:01 pmRNSSales update
3rd Jan 200610:18 amRNSAdditional Listing
3rd Jan 20067:00 amRNSDirector/PDMR Shareholding
23rd Dec 200510:00 amRNSCAT Annual Report sent to FSA
20th Dec 20053:32 pmRNSHolding(s) in Company
20th Dec 20053:29 pmRNSDirector/PDMR Shareholding
5th Dec 200511:23 amRNSDirector/PDMR Shareholding
1st Dec 20053:36 pmRNSDirector/PDMR Shareholding
28th Nov 20054:11 pmRNSDirector/PDMR Shareholding
28th Nov 20057:02 amRNSFinal Results
25th Nov 20053:33 pmRNSDirector/PDMR Shareholding
1st Nov 20057:01 amRNSProduct Candidate Acquisition
27th Oct 20053:46 pmRNSNotice of Results
26th Oct 20057:01 amRNSCAT & ABBOTT AGREE ROYALTIES
12th Oct 20055:12 pmRNSHolding(s) in Company
5th Oct 20053:30 pmRNSResearch Update
30th Sep 20052:55 pmRNSBlocklisting Interim Review
30th Sep 20052:52 pmRNSBlocklisting Interim Review
30th Sep 20052:46 pmRNSBlocklisting Interim Review
23rd Sep 20054:34 pmRNSHolding(s) in Company
15th Sep 20054:19 pmRNSDirector/PDMR Shareholding
12th Sep 20057:01 amRNSDirectorate Change
12th Sep 20057:01 amRNS3rd Quarter Results
19th Aug 20059:39 amRNSHolding(s) in Company
18th Aug 200510:01 amRNSHolding(s) in Company
15th Aug 200510:17 amRNSNotice of Results
23rd Jun 20057:01 amRNSCAT-354 Clinical Update
1st Jun 20055:20 pmRNSHolding(s) in Company
20th May 20058:00 amRNSUpdate re Abbott
19th May 200512:31 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.